Skip to main content
SpringerLink
Log in

Antineoplastic-induced HSRs can be prevented and managed in many cases

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zanotti KM, Markman M. Prevention and management of antineoplastic-induced HSRs. Drug Saf 2001; 24(10): 767–79

    Article  PubMed  CAS  Google Scholar 

  2. Markman, M., Kennedy, A., Webster, K., et al. Simplified regimen for the prevention of paclitaxel-associated HSRs [letter]. J Clin Oncol 1997 Dec; 15(12): 3517

    PubMed  CAS  Google Scholar 

  3. Bookman MA, Kloth DD, Kover PE, et al. Intravenous prophylaxis for paclitaxel-related HSRs. Semin Oncol 1997 Dec; 24 (6 Suppl. 19):S3–S15

    Google Scholar 

  4. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995 Aug; 13(8): 1860–70

    PubMed  CAS  Google Scholar 

  5. Markman M, Kennedy A, Webster K, et al. Paclitaxel-associated HSRs: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. J Clin Oncol 2000 Jan; 18(1): 102–5

    PubMed  CAS  Google Scholar 

  6. Markman M, Kennedy A, Webster K, et al. Clinical features of HSRs to carboplatin. J Clin Oncol 1999 Apr; 17(4): 1141

    PubMed  CAS  Google Scholar 

  7. Billett AL, Carls A, Gelber RD, et al. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer 1992 Jul 1; 70(1): 201–6

    Article  PubMed  CAS  Google Scholar 

  8. Kellie SJ, Crist WM, Pui CH, et al. HSRs to epipodophyllotoxins in children with acute lymphoblastic leukemia. Cancer 1991 Feb 15; 67(4): 1070–5

    Article  PubMed  CAS  Google Scholar 

  9. O’Dwyer PJ, King SA, Fortner CL, et al. HSRs to teniposide (VM-26): an analysis. J Clin Oncol 1986 Aug; 4(8): 1262–9

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antineoplastic-induced HSRs can be prevented and managed in many cases. Drugs Ther. Perspect 18, 22–25 (2002). https://doi.org/10.2165/00042310-200218070-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218070-00007

Keywords

Search

Navigation